Brian G. Feagan, MD

Western University
London, ON, Canada

Presentation(s):

• 32 - Pharmacokinetics, Exposure-Response Relationships, and Immunogenicity in Crohn’s Disease Patients with Ustekinumab Secondary Loss of Response Following Ustekinumab IV Re-Induction: Week 16 Results from the POWER Study

  Tuesday, October 24, 2023
  9:10 AM – 9:20 AM PT